Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Predictive utility of subtyping women smokers on depression, eating, and weight-related symptoms.

Salk RH, Germeroth LJ, Emery RL, Conlon RPK, Wang Z, Cheng Y, Marcus MD, Perkins KA, Levine MD.

Health Psychol. 2019 Mar;38(3):248-258. doi: 10.1037/hea0000702.

PMID:
30762404
2.

A Procedure to Standardize Puff Topography During Evaluations of Acute Tobacco or Electronic Cigarette Exposure.

Perkins KA, Karelitz JL.

Nicotine Tob Res. 2018 Dec 8. doi: 10.1093/ntr/nty261. [Epub ahead of print]

PMID:
30590778
3.

Influenza A(H3N2) Variant Virus Outbreak at Three Fairs - Maryland, 2017.

Duwell MM, Blythe D, Radebaugh MW, Kough EM, Bachaus B, Crum DA, Perkins KA Jr, Blanton L, Davis CT, Jang Y, Vincent A, Chang J, Abney DE, Gudmundson L, Brewster MG, Polsky L, Rose DC, Feldman KA.

MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1169-1173. doi: 10.15585/mmwr.mm6742a1.

4.

Quantifying the relationship between optical anatomy and retinal physiological sensitivity: A comparative approach.

Rosencrans RF, Leslie CE, Perkins KA, Walkowski W, Gordon WC, Richards-Zawacki CL, Bazan NG, Farris HE.

J Comp Neurol. 2018 Dec 15;526(18):3045-3057. doi: 10.1002/cne.24531. Epub 2018 Oct 31.

PMID:
30198557
5.

Acute perceptions of preferred cigarettes when blinded to brand.

Perkins KA, Karelitz JL.

Tob Control. 2019 May;28(3):311-316. doi: 10.1136/tobaccocontrol-2018-054388. Epub 2018 Jul 10.

PMID:
29991640
6.

Discrimination of nicotine content in electronic cigarettes.

Perkins KA, Herb T, Karelitz JL.

Addict Behav. 2019 Apr;91:106-111. doi: 10.1016/j.addbeh.2018.05.027. Epub 2018 May 29.

PMID:
29871789
7.

Tobacco smoking may delay habituation of reinforcer effectiveness in humans.

Karelitz JL, Perkins KA.

Psychopharmacology (Berl). 2018 Aug;235(8):2315-2321. doi: 10.1007/s00213-018-4927-3. Epub 2018 May 18.

PMID:
29777289
8.

FDA Policy on Setting Maximum Nicotine Content in Cigarettes.

Perkins KA.

Nicotine Tob Res. 2019 Jun 21;21(7):996-997. doi: 10.1093/ntr/nty068. No abstract available.

PMID:
29660048
9.

Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray.

Perkins KA, Karelitz JL, Boldry MC.

Nicotine Tob Res. 2019 May 21;21(6):778-783. doi: 10.1093/ntr/nty038.

10.

Evaluation of menthol per se on acute perceptions and behavioral choice of cigarettes differing in nicotine content.

Perkins KA, Karelitz JL, Kunkle N.

J Psychopharmacol. 2018 Mar;32(3):324-331. doi: 10.1177/0269881117742660. Epub 2018 Feb 22.

PMID:
29468937
11.

ANALYSIS OF AGREEMENT BETWEEN EXPIRED-AIR CARBON MONOXIDE MONITORS.

Karelitz JL, Michael VC, Perkins KA.

J Smok Cessat. 2017 Jun;12(2):105-112. doi: 10.1017/jsc.2015.18. Epub 2016 Feb 2.

12.

Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Perkins KA, Roy Chengappa KN, Karelitz JL, Boldry MC, Michael V, Herb T, Gannon J, Brar J, Ford L, Rassnick S, Brunzell DH.

Neuropsychopharmacology. 2018 May;43(6):1334-1342. doi: 10.1038/npp.2017.292. Epub 2017 Nov 29.

13.

Sex Differences in Subjective Responses To Moderate Versus Very Low Nicotine Content Cigarettes.

Perkins KA, Karelitz JL, Kunkle N.

Nicotine Tob Res. 2018 Sep 4;20(10):1258-1264. doi: 10.1093/ntr/ntx205.

PMID:
29059330
14.

Comparison of Parent Report and Direct Assessment of Child Skills in Toddlers.

Miller LE, Perkins KA, Dai YG, Fein DA.

Res Autism Spectr Disord. 2017 Sep;41-42:57-65. doi: 10.1016/j.rasd.2017.08.002. Epub 2017 Aug 30.

15.

Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence.

Perkins KA, Karelitz JL, Michael VC.

Exp Clin Psychopharmacol. 2017 Aug;25(4):249-254. doi: 10.1037/pha0000134. Epub 2017 Jun 26.

16.

Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans.

Perkins KA, Karelitz JL, Boldry MC.

Front Psychiatry. 2017 May 1;8:65. doi: 10.3389/fpsyt.2017.00065. eCollection 2017. Review.

17.

Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers.

Perkins KA, Kunkle N, Karelitz JL, Perkins KA, Kunkle N, Karelitz JL.

Drug Alcohol Depend. 2017 Jun 1;175:36-41. doi: 10.1016/j.drugalcdep.2017.01.033. Epub 2017 Mar 23.

18.

Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers.

Perkins KA, Kunkle N, Karelitz JL.

Psychopharmacology (Berl). 2017 Apr;234(8):1255-1265. doi: 10.1007/s00213-017-4563-3. Epub 2017 Feb 16.

PMID:
28210778
19.

Validating Use of Internet-Submitted Carbon Monoxide Values by Video to Determine Quit Status.

Karelitz JL, Michael VC, Boldry M, Perkins KA.

Nicotine Tob Res. 2017 Aug 1;19(8):990-993. doi: 10.1093/ntr/ntw311.

20.

Potential sex differences in the pattern of sensory reinforcers enhanced by nicotine.

Perkins KA, Karelitz JL.

Exp Clin Psychopharmacol. 2016 Jun;24(3):156-61. doi: 10.1037/pha0000073. Epub 2016 Apr 28.

21.

Threshold dose for discrimination of nicotine via cigarette smoking.

Perkins KA, Kunkle N, Karelitz JL, Michael VC, Donny EC.

Psychopharmacology (Berl). 2016 Jun;233(12):2309-17. doi: 10.1007/s00213-016-4281-2. Epub 2016 Apr 2.

22.

Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking.

Perkins KA, Kunkle N, Michael VC, Karelitz JL, Donny EC.

Nicotine Tob Res. 2016 Sep;18(9):1830-6. doi: 10.1093/ntr/ntw082. Epub 2016 Mar 24.

23.

Reinforcement enhancing effects of acute nicotine via electronic cigarettes.

Perkins KA, Karelitz JL, Michael VC.

Drug Alcohol Depend. 2015 Aug 1;153:104-8. doi: 10.1016/j.drugalcdep.2015.05.041. Epub 2015 Jun 6.

24.

Dr Chengappa and colleagues reply.

Chengappa KN, Perkins KA, Brar JS, Turkin SR, Levine MD, George TP.

J Clin Psychiatry. 2015 May;76(5):625-6. doi: 10.4088/JCP.14lr09456a. No abstract available.

25.

Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.

Perkins KA, Karelitz JL, Michael VC, Fromuth M, Conklin CA, Chengappa KN, Hope C, Lerman C.

Nicotine Tob Res. 2016 Jan;18(1):74-8. doi: 10.1093/ntr/ntv085. Epub 2015 Apr 20.

26.

Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes.

Perkins KA, Karelitz JL.

Nicotine Tob Res. 2015 Apr;17(4):443-8. doi: 10.1093/ntr/ntu150.

27.

Examining the relationship between cue-induced craving and actual smoking.

Conklin CA, Vella EJ, Joyce CJ, Salkeld RP, Perkins KA, Parzynski CS.

Exp Clin Psychopharmacol. 2015 Apr;23(2):90-6. doi: 10.1037/a0038826. Epub 2015 Mar 2.

28.

An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder.

Forrest PE, Brinson AJ, Gannon JM, George TP, Perkins KA, Chengappa KN.

J Clin Psychopharmacol. 2015 Apr;35(2):199-200. doi: 10.1097/JCP.0000000000000272. No abstract available.

29.

Sensory reinforcement-enhancing effects of nicotine via smoking.

Perkins KA, Karelitz JL.

Exp Clin Psychopharmacol. 2014 Dec;22(6):511-6. doi: 10.1037/a0037823. Epub 2014 Sep 1.

30.

Improving efficiency of initial tests for efficacy in smoking cessation drug discovery.

Perkins KA.

Expert Opin Drug Discov. 2014 Nov;9(11):1259-64. doi: 10.1517/17460441.2014.951632. Epub 2014 Aug 20. Review.

PMID:
25138487
31.

Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.

Chengappa KN, Perkins KA, Brar JS, Schlicht PJ, Turkin SR, Hetrick ML, Levine MD, George TP.

J Clin Psychiatry. 2014 Jul;75(7):765-72. doi: 10.4088/JCP.13m08756.

PMID:
25006684
32.

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, Swann R, Dwek M, Perkins KA, Gillett C, Houlston R, Ross G, De Ieso P, Southey MC, Hopper JL, Provenzano E, Apicella C, Wesseling J, Cornelissen S, Keeman R, Fasching PA, Jud SM, Ekici AB, Beckmann MW, Kerin MJ, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Kerbrat P, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JI, Menéndez P, Benitez J, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Lochmann M, Brauch H, Fischer HP, Ko YD; GENICA Network, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G, Investigators K, Lambrechts D, Weltens C, Van Limbergen E, Hatse S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Volorio S, Giles GG, Severi G, Baglietto L, McLean CA, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Kristensen V, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devillee P, Tollenaar RA, Seynaeve CM, Kriege M, Figueroa J, Chanock SJ, Sherman ME, Hooning MJ, Hollestelle A, van den Ouweland AM, van Deurzen CH, Li J, Czene K, Humphreys K, Cox A, Cross SS, Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Couch FJ, Hallberg E, González-Neira A, Pita G, Alonso MR, Tessier DC, Vincent D, Bacot F, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Hall P, Easton D, Pharoah P, Schmidt MK, Tomlinson I, Garcia-Closas M.

PLoS Genet. 2014 Apr 17;10(4):e1004285. doi: 10.1371/journal.pgen.1004285. eCollection 2014 Apr.

33.

An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.

Perkins KA, Lerman C.

Psychopharmacology (Berl). 2014 Jan;231(1):1-11. doi: 10.1007/s00213-013-3364-6. Epub 2013 Dec 3. Review.

34.

Do people serve as cues to smoke?

Conklin CA, Salkeld RP, Perkins KA, Robin N.

Nicotine Tob Res. 2013 Dec;15(12):2081-7. doi: 10.1093/ntr/ntt104. Epub 2013 Jul 19.

35.

Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.

Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM.

Addiction. 2013 Nov;108(11):1962-8. doi: 10.1111/add.12273. Epub 2013 Jul 12.

36.

Influence of reinforcer magnitude and nicotine amount on smoking's acute reinforcement enhancing effects.

Perkins KA, Karelitz JL.

Drug Alcohol Depend. 2013 Nov 1;133(1):167-71. doi: 10.1016/j.drugalcdep.2013.05.016. Epub 2013 Jun 13.

37.

Effects of bupropion on cognitive performance during initial tobacco abstinence.

Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C.

Drug Alcohol Depend. 2013 Nov 1;133(1):283-6. doi: 10.1016/j.drugalcdep.2013.05.003. Epub 2013 May 31.

38.

The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence.

Ashare RL, Wileyto EP, Perkins KA, Schnoll RA.

J Addict Med. 2013 Jul-Aug;7(4):249-54. doi: 10.1097/ADM.0b013e31829363e1.

39.

The DietCompLyf study: a prospective cohort study of breast cancer survival and phytoestrogen consumption.

Swann R, Perkins KA, Velentzis LS, Ciria C, Dutton SJ, Mulligan AA, Woodside JV, Cantwell MM, Leathem AJ, Robertson CE, Dwek MV.

Maturitas. 2013 Jul;75(3):232-40. doi: 10.1016/j.maturitas.2013.03.018. Epub 2013 May 8.

PMID:
23664318
40.

CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.

Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL.

Subst Use Misuse. 2013 May;48(7):490-4. doi: 10.3109/10826084.2013.778280. Epub 2013 Mar 25.

41.

Reinforcement enhancing effects of nicotine via smoking.

Perkins KA, Karelitz JL.

Psychopharmacology (Berl). 2013 Aug;228(3):479-86. doi: 10.1007/s00213-013-3054-4. Epub 2013 Mar 15.

42.

Modulating roles of smoking status and sex on oxycodone-induced nausea and drug liking.

Zacny JP, Apfelbaum SM, Perkins KA.

Exp Clin Psychopharmacol. 2013 Apr;21(2):103-11. doi: 10.1037/a0031706. Epub 2013 Feb 18.

PMID:
23421355
43.

Emulating natural disturbances for declining late-successional species: a case study of the consequences for cerulean warblers (Setophaga cerulea).

Boves TJ, Buehler DA, Sheehan J, Wood PB, Rodewald AD, Larkin JL, Keyser PD, Newell FL, George GA, Bakermans MH, Evans A, Beachy TA, McDermott ME, Perkins KA, White M, Wigley TB.

PLoS One. 2013;8(1):e52107. doi: 10.1371/journal.pone.0052107. Epub 2013 Jan 4.

44.

Possible reinforcement enhancing effects of bupropion during initial smoking abstinence.

Perkins KA, Karelitz JL, Jao NC, Stratton E.

Nicotine Tob Res. 2013 Jun;15(6):1141-5. doi: 10.1093/ntr/nts224. Epub 2012 Oct 24.

45.

Consistency of daily cigarette smoking amount in dependent adults.

Perkins KA, Jao NC, Karelitz JL.

Psychol Addict Behav. 2013 Sep;27(3):723-9. doi: 10.1037/a0030287. Epub 2012 Oct 22.

46.

Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Perkins KA, Karelitz JL, Jao NC.

Nicotine Tob Res. 2013 May;15(5):978-82. doi: 10.1093/ntr/nts205. Epub 2012 Sep 18.

47.

Cue reactivity as a predictor of successful abstinence initiation among adult smokers.

Conklin CA, Parzynski CS, Salkeld RP, Perkins KA, Fonte CA.

Exp Clin Psychopharmacol. 2012 Dec;20(6):473-8. doi: 10.1037/a0029599. Epub 2012 Aug 13.

48.

Dietary intake after smoking cessation among weight-concerned women smokers.

Levine MD, Cheng Y, Kalarchian MA, Perkins KA, Marcus MD.

Psychol Addict Behav. 2012 Dec;26(4):969-73. doi: 10.1037/a0028948. Epub 2012 Jul 16.

49.

Negative mood effects on craving to smoke in women versus men.

Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA.

Addict Behav. 2013 Feb;38(2):1527-31. doi: 10.1016/j.addbeh.2012.06.002. Epub 2012 Jun 7.

50.

Smoking in response to negative mood in men versus women as a function of distress tolerance.

Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C.

Nicotine Tob Res. 2012 Dec;14(12):1418-25. doi: 10.1093/ntr/nts075. Epub 2012 Mar 13.

Supplemental Content

Loading ...
Support Center